title: Long-term results of the R-CEOP90 in the treatment of young patients with chemotherapy-naïve diffuse large B cell lymphoma: a phase II study.
authors: Department of Medical Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences , Guangzhou , China.
authors: Qi-Chun
authors: QC
authors: Cai
authors: Yan
authors: Y
authors: Gao
authors: Xiao-Xiao
authors: XX
authors: Wang
authors: Qing-Qing
authors: QQ
authors: Cai
authors: Ze-Xiao
authors: ZX
authors: Lin
authors: Bing
authors: B
authors: Bai
authors: Ying
authors: Y
authors: Guo
authors: Hui-Qiang
authors: HQ
authors: Huang
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D011239:Prednisolone; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D015251:Epirubicin; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone